USPTO serial 79003755
BETOVAC
Reviewed by CopyMark Law Group
Reg. 3004590Status 404
- Filing date
- Status date
- Registration date
- Oct 4, 2005
- Examiner
- BENMAMAN, ALICE
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BETOVAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CARROLLANNE LINDLEY,
JOHN C CAIN WONG, CABELLO, LUTSCH, RUTHERFORD & BRUC20333 SH 249 STE 600HOUSTON, TX 77070UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines, for use in gene therapy; therapeutic compositions containing lipsome reagents or nucleic acid suitable for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations, namely, vaccines, for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes; retroviral vector and retroviral vector manufacturing preparations; chemotherapeutics for medical use | SECTION 71 - CANCELLED | — |
| 010 | Instruments and apparatus for the administration of gene therapy products, namely, Pre-filled vials, syringes and injectors, catheters, and tubes; surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clips | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford Biomedica plc
- Other trademarks owned by Oxford Biomedica plc
- Other trademarks owned by Oxford Biomedica plc
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BETOVAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2014 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Sep 18, 2014 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 16, 2014 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 31, 2014 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 18, 2013 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 18, 2013 | C71T | CANCELLED SECTION 71 | — |
| Sep 1, 2007 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2006 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 19, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 4, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 12, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| May 2, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 31, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 25, 2005 | ALIE | ASSIGNED TO LIE | — |
| Mar 23, 2005 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 22, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 22, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 3, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 14, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2005 | PAPER RECEIVED | — | |
| Oct 22, 2004 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 12, 2004 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |